StonvexLoading…
StonvexCore line items from ARX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $912.90M | $602.60M | $344.00M |
Operating Income | $-1.32B | $32.00M | $-43.90M |
Net Income | $-1.35B | $22.90M | $-64.10M |
EPS (Diluted) | $-7.49 | $0.14 | $-0.29 |
Total Assets | $8.26B | $6.09B | Not available |
Total Liabilities | $7.54B | $5.67B | Not available |
Cash & Equivalents | $1.72B | $1.23B | $775.40M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available |
Shares Outstanding | 190.26M | 166.19M | 165.60M |